Health TrialsbyHealthPanel

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors.

This is an open label Phase 1, First in Human trial designed to evaluate the safety, tolerability pharmacokinetics, preliminary efficacy of BA1301 in participants with advanced solid tumors.

Participants needed: 70
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Shandong Boan Biotechnology Co., LtdUpdated: Oct 13, 2026Locations: 1
Eligibility criteria

Voluntarily signed informed consent and able to follow the trial treatment proto... [+8]

Poorly controlled hypertension as judged by the investigator [+6]

Read more
Status: Recruiting

Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

This is a first-in-human (FIH), multicenter, open-label Phase I study to evaluate the safety, tolerability, PK profile, immunogenicity, and preliminary efficacy of BA1302 in patients with advanced solid malignancies. The study includes a dose-escalation phase (Part A) and a dose-expansion phase (Part B).

Participants needed: 167
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Shandong Boan Biotechnology Co., LtdUpdated: Oct 13, 2026Locations: 1
Eligibility criteria

1. Metastatic or unresectable solid malignancy that is histologically or cytolog... [+5]

1. Malignant disease within 5 years prior to the first dose of investigational d... [+4]

Read more
Status: Recruiting

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors

This is an open label Phase 1, First in Human trial designed to evaluate the safety, tolerability pharmacokinetics, preliminary efficacy of BA1106 in participants with advanced solid tumors.

Participants needed: 177
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Shandong Boan Biotechnology Co., LtdUpdated: Oct 13, 2026Locations: 1
Eligibility criteria

Able and willing to provide written informed consent and to comply with the stud... [+8]

Participants with active central nervous system (CNS) metastases causing clinica... [+21]

Read more
Status: Recruiting

A Study of BA1202 in Patients With Advanced Solid Tumors

This is a multicenter, open-label, single-arm phase I study in patients with advanced solid tumors which consists of a dose escalation part (Part A) and a dose extension part (Part B). Part A aims to evaluate the safety and tolerability of BA1202, and determine the MTD. Part B will also evaluate the preliminary efficacy of BA1202.

Participants needed: 78
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Shandong Boan Biotechnology Co., LtdUpdated: Apr 25, 2024Locations: 1
Eligibility criteria

Patients who voluntarily sign an IRB-approved informed consent form, and are wil... [+11]

Other malignancies within 5 years prior to screening (other than cured stage Ib... [+8]

Read more